Presentation at San Antonio Breast Cancer Symposium on Dec. 11, 2025. Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on ...
News
- Anixa Biosciences Announces Phase 1 Breast Cancer Vaccine Data - AInvest
- Anixa Biosciences (ANIX) to Reveal Key Phase 1 Results at SABCS 2025 - GuruFocus
Anixa Biosciences (ANIX) will unveil the final outcomes of its Phase 1 clinical trial for a breast cancer vaccine at the San Antonio Breast Cancer ...
- Fierce Biotech names Incyclix Bio a “Fierce 15” Biotech Company of 2025 - Yahoo Finance
At the 2024 San Antonio Breast Cancer Symposium, the Company announced interim clinical data demonstrating the safety and efficacy of INX-315 from ...
- Roche declares Phase 3 win for SERD in broad breast cancer population that eluded competitors
The San Antonio Breast Cancer Symposium, to be held in Texas in ... Bioscience & Technology Business Center The University of Kansas Lawrence ...
- Anixa's Breast Cancer Vaccine Phase 1 Results Set for SABCS 2025 | ANIX Stock News
... San Antonio Breast Cancer Symposium on December 11, 2025. The trial ... ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company ...